🇺🇸 FDA
Patent

US 10548890

Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

granted A61KA61K31/255A61K31/496

Quick answer

US patent 10548890 (Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same) held by Platform Brightworks Two, Ltd. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Platform Brightworks Two, Ltd.
Grant date
Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/255, A61K31/496, A61K47/02, A61K47/10